VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease
NCT00114465
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Crohn's Disease
Interventions
DRUG:
VSL#3
OTHER:
Placebo
Sponsor
Orphan Australia